Fulcrum Therapeutics, Inc.
Develops gene-modulating small molecule drugs for rare, genetically defined diseases.
FULC | NDAQ
Overview
Corporate Details
- ISIN(s):
- US3596161097
- LEI:
- Country:
- United States of America
- Address:
- 26 LANDSDOWNE STREET, 2139 CAMBRIDGE
- Website:
- https://www.fulcrumtx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for genetically defined rare diseases in areas of high unmet medical need. The company leverages its proprietary product engine to identify drug targets that can modulate gene expression to treat the known root cause of a disease. Fulcrum's primary focus is on discovering and developing small molecule drugs designed to be disease-modifying. Its patient-centered approach aims to create therapies that can transform the lives of patients and their caregivers by addressing the underlying genetic drivers of their conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Fulcrum Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fulcrum Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fulcrum Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
